Preoperative quality of life in gynecologic oncology patients: A new predictor of operative risk?
Kemi M. Doll(University of Washington), Paola A. Gehrig(University of North Carolina at Chapel Hill), Wendy R. Brewster(University of North Carolina at Chapel Hill), DE Irwin(University of North Carolina at Chapel Hill), John F. Boggess(University of Kentucky), Jeannette T. Bensen(University of North Carolina at Chapel Hill), John T. Soper(University of North Carolina at Chapel Hill), Anna C. Snavely(Brigham and Women's Hospital), Anne Kalinowski(University of Pittsburgh), Victoria Bae‐Jump(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458